Global Wealth Strategies & Associates »

Arcturus Therapeutics Hldg I shares owned by Global Wealth Strategies & Associates

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by Global Wealth Strategies & Associates from 13F filings

Historical chart of Global Wealth Strategies & Associates investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by Global Wealth Strategies & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by Global Wealth Strategies & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2k 100 31.53
2023-09-30 $2.6k 100 25.55

More positions owned by Global Wealth Strategies & Associates

Vanguard S&p 500 Etf Etf (VOO)
Ishares Core Msci Eafe Etf Etf (IEFA)
Invesco Nasdaq 100 Etf Etf (QQQM)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Dividend Appreciation Etf Etf (VIG)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Vanguard Mortgage-backed Securities Etf Etf (VMBS)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Ishares National Muni Bond Etf Etf (MUB)
Ishares U.s. Treasury Bond Etf Etf (GOVT)
Ishares Gold Trust Etf (IAU)
Vanguard Short-term Bond Etf Etf (BSV)
Energy Select Sector Spdr Fund Etf (XLE)
Sherwin Williams Stock (SHW)
Invesco Qqq Trust Series I Etf (QQQ)

View all positions for Global Wealth Strategies & Associates

Top funds holding Arcturus Therapeutics Hldg I

Federated Investors
ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Dimensional Fund Advisors
Goldman Sachs Group
Schonfeld Strategic Advisors
Jupiter Asset Management
Jpmorgan Chase & Co
Wintrust Financial Corporation
Charles Schwab Investment Management
AQR Capital Management
Caption Management
Portolan Capital Management

View all funds holding Arcturus Therapeutics Hldg I